Methotrexate + infliximab vs infliximab
Failure to enter remission at 14 weeks or 24 weeks (Feagan 2014) · adult patients with refractory Crohn's disease
It is very uncertain whether methotrexate + infliximab changes failure to enter remission at 14 weeks or 24 weeks (Schröder 2006) compared with infliximab alone (very low certainty).
1 finding from 1 review
- Methotrexate for induction of remission in refractory Crohn's disease 2014 · Cochrane Headline outcomes onlyRR 0.73 [0.31, 1.69]1 study · 19 participantsVery low